AR071217A1 - Derivados bencimidazol - Google Patents
Derivados bencimidazolInfo
- Publication number
- AR071217A1 AR071217A1 ARP090101462A ARP090101462A AR071217A1 AR 071217 A1 AR071217 A1 AR 071217A1 AR P090101462 A ARP090101462 A AR P090101462A AR P090101462 A ARP090101462 A AR P090101462A AR 071217 A1 AR071217 A1 AR 071217A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- integer
- compounds
- represents hydrogen
- bencimidazol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se relaciona con compuesto de formula (1) en la cual R1 representa arilo, que está no sustituido, o mono-, di-, o trisustituido en donde los sustituyentes son seleccionados de manera independiente desde el grupo que consiste en alquilo C1-4, alcoxilo C1-4, halogeno, y trifluorometilo; R2 representa hidrogeno, o -CO-R21, R21 representa alquilo C1-5, fluoroalquilo C1-3, o cicloalquilo C3-6; m representa el entero 2, o 3; p representa el entero 2 o 3; y R3 representa hidrogeno, o alquilo C1-5; y sales farmacéuticamente aceptables de tales compuestos. Estos compuestos son utiles como bloqueadores de panales de calcio. También se reivindica la composicion farmacéutica y uso para preparar medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2008051602 | 2008-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR071217A1 true AR071217A1 (es) | 2010-06-02 |
Family
ID=40823387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101462A AR071217A1 (es) | 2008-04-25 | 2009-04-24 | Derivados bencimidazol |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110039905A1 (es) |
| EP (1) | EP2271628A1 (es) |
| JP (1) | JP4806734B2 (es) |
| KR (1) | KR101364909B1 (es) |
| CN (1) | CN102015658B (es) |
| AR (1) | AR071217A1 (es) |
| AU (1) | AU2009239620A1 (es) |
| BR (1) | BRPI0911538B1 (es) |
| CA (1) | CA2722067A1 (es) |
| IL (1) | IL208856A0 (es) |
| MX (1) | MX2010011459A (es) |
| NZ (1) | NZ589509A (es) |
| RU (1) | RU2478095C2 (es) |
| TW (1) | TWI401249B (es) |
| WO (1) | WO2009130679A1 (es) |
| ZA (1) | ZA201008448B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008132679A1 (en) | 2007-04-27 | 2008-11-06 | Actelion Pharmaceuticals Ltd | Bridged six-membered ring compounds |
| CN102186828B (zh) | 2008-10-22 | 2014-07-16 | 埃科特莱茵药品有限公司 | 异丁酸(1r*,2r*,4r*)-2-(2-{[3-(4,7-二甲氧基-1h-苯并咪唑-2-基)-丙基]-甲基-胺基}-乙基)-5-苯基-二环[2.2.2]辛-5-烯-2-基酯的盐 |
| US8314253B2 (en) | 2008-10-22 | 2012-11-20 | Actelion Pharmaceuticals Ltd. | Bridged tetrahydronaphthalene derivatives |
| WO2010046729A2 (en) * | 2008-10-23 | 2010-04-29 | Actelion Pharmaceuticals Ltd | Tetrahydronaphthalene compounds |
| KR101876594B1 (ko) | 2010-10-20 | 2018-08-02 | 아이도시아 파마수티컬즈 리미티드 | 바이시클로[2.2.2]옥탄-2-온 화합물의 제조 |
| KR101836552B1 (ko) * | 2010-10-20 | 2018-03-08 | 아이도시아 파마수티컬즈 리미티드 | 바이시클로[2.2.2]옥탄-2-온 화합물의 부분입체선택적 제조 |
| WO2015182724A1 (ja) | 2014-05-28 | 2015-12-03 | トーアエイヨー株式会社 | 置換トロパン誘導体 |
| EP3996746A4 (en) | 2019-07-11 | 2023-08-23 | Praxis Precision Medicines, Inc. | T-TYPE CALCIUM CHANNEL MODULATOR FORMULATIONS AND METHODS OF USE THEREOF |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1319144C (en) * | 1986-11-14 | 1993-06-15 | Quirico Branca | Tetrahydronaphthalene derivatives |
| US6268377B1 (en) * | 1998-09-28 | 2001-07-31 | Merck & Co., Inc. | Method for treating androgen-related conditions |
| CA2462913A1 (en) * | 2001-10-10 | 2003-04-17 | Aryx Therapeutics | Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina |
| WO2008132679A1 (en) * | 2007-04-27 | 2008-11-06 | Actelion Pharmaceuticals Ltd | Bridged six-membered ring compounds |
-
2009
- 2009-04-23 BR BRPI0911538-2A patent/BRPI0911538B1/pt not_active IP Right Cessation
- 2009-04-23 CN CN2009801155609A patent/CN102015658B/zh not_active Expired - Fee Related
- 2009-04-23 AU AU2009239620A patent/AU2009239620A1/en not_active Abandoned
- 2009-04-23 KR KR1020107026438A patent/KR101364909B1/ko not_active Expired - Fee Related
- 2009-04-23 WO PCT/IB2009/051668 patent/WO2009130679A1/en not_active Ceased
- 2009-04-23 RU RU2010147865/04A patent/RU2478095C2/ru active
- 2009-04-23 EP EP09734909A patent/EP2271628A1/en not_active Withdrawn
- 2009-04-23 NZ NZ589509A patent/NZ589509A/en not_active IP Right Cessation
- 2009-04-23 JP JP2011505634A patent/JP4806734B2/ja not_active Expired - Fee Related
- 2009-04-23 MX MX2010011459A patent/MX2010011459A/es active IP Right Grant
- 2009-04-23 US US12/989,443 patent/US20110039905A1/en not_active Abandoned
- 2009-04-23 CA CA2722067A patent/CA2722067A1/en not_active Abandoned
- 2009-04-24 AR ARP090101462A patent/AR071217A1/es unknown
- 2009-04-24 TW TW098113755A patent/TWI401249B/zh not_active IP Right Cessation
-
2010
- 2010-10-21 IL IL208856A patent/IL208856A0/en unknown
- 2010-11-24 ZA ZA2010/08448A patent/ZA201008448B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2478095C2 (ru) | 2013-03-27 |
| JP4806734B2 (ja) | 2011-11-02 |
| CN102015658B (zh) | 2013-03-20 |
| KR20110011639A (ko) | 2011-02-08 |
| TWI401249B (zh) | 2013-07-11 |
| CN102015658A (zh) | 2011-04-13 |
| CA2722067A1 (en) | 2009-10-29 |
| HK1155739A1 (en) | 2012-05-25 |
| ZA201008448B (en) | 2012-04-25 |
| AU2009239620A1 (en) | 2009-10-29 |
| TW200944507A (en) | 2009-11-01 |
| IL208856A0 (en) | 2011-01-31 |
| MX2010011459A (es) | 2010-11-12 |
| US20110039905A1 (en) | 2011-02-17 |
| EP2271628A1 (en) | 2011-01-12 |
| JP2011518821A (ja) | 2011-06-30 |
| RU2010147865A (ru) | 2012-05-27 |
| BRPI0911538A2 (pt) | 2020-01-07 |
| WO2009130679A1 (en) | 2009-10-29 |
| BRPI0911538B1 (pt) | 2021-05-18 |
| KR101364909B1 (ko) | 2014-02-21 |
| NZ589509A (en) | 2012-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR071217A1 (es) | Derivados bencimidazol | |
| AR064561A1 (es) | Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina. | |
| AR070459A1 (es) | Derivados de 2-aza-biciclo- [2,2,1] heptano | |
| EA201001682A1 (ru) | Производные фенил- и бензодиоксинилзамещенных индазолов | |
| PE20142456A1 (es) | COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| UY31254A1 (es) | Derivados sutituidos de n4-(5-metil-1h-pirazol-3-il)- 1,3,5-triazina-2,4-diamina, sus enantiómeros, sales farmacéuticamente aceptables de los mismos, composiciones, procesos de preparación y aplicaciones | |
| AR072906A1 (es) | Nucleosidos modificados utiles como antivirales | |
| AR082886A1 (es) | Compuestos y composiciones farmaceuticas que los contienen | |
| PE20181304A1 (es) | Derivados de indol n-sustituidos como moduladores de los receptores de pge2 | |
| AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| PE20190337A1 (es) | NUEVOS DERIVADOS DE PIRROLO [2,3-d]PIRIMIDA, UN PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| AR084153A1 (es) | Derivados de pirimidinona | |
| UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
| CO6150038A1 (es) | Nuevos derivados de diosmetina su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
| AR069607A1 (es) | Inhibidores de la estearoil-coa desaturasa | |
| EA201490722A1 (ru) | ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНОГО РЕЦЕПТОРА ГЛУТАМАТА mGluR5 | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| UY32055A (es) | Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones. | |
| AR098818A1 (es) | Derivados de oxindol, preparación de los mismos y uso terapéutico de los mismos | |
| AR054277A1 (es) | Derivados de piperidin - 4 - il - amida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con la modulacion de receptores del subtipo 5 de la sst. | |
| UY30933A1 (es) | Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones farmacéuticas que contienen tales compuestos y aplicaciones. | |
| AR069387A1 (es) | Compuestos de cicloalquiloxi -y heterocicloalquiloxipiridina como moduladores del receptor de histamina h3 | |
| ES2571553T3 (es) | Procedimiento para la preparación de oxindoles sustituidos con triazinilo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |